The national palliative care guidelines make recommendations about the use of various drugs.  These recommendations should be considered alongside the information contained below.

It is recognised that some medicines will be initiated by a specialist and care may transfer to a generalist setting. The presentation, indications, doses and routes of administration may be unfamiliar to practitioners and medicines information sheets will be made available. The medicine information sheets are  colour coded to indicate medicines used under specialist guidance and those for more general use.

Red– For medicines normally initiated and used under specialist guidance

Amber – For medicines normally initiated by a specialist but may be used by generalists

Green – For medicines routinely initiated and used by generalists

 

The following medicines are coded green

The following medicines are coded amber

The following medicines are coded red

Expand this content

Alfentanil 5 mg/5 ml sublingual spray - patient information leaflet

Atropine sulfate 1% w/v eye drops used in the mouth for excess saliva - patient information leaflet

Buccal midazolam for seizures - patient information leaflet

Hyoscine Hydrobromide (Scopoderm) patient information leaflet

Ipratropium bromide for excess saliva - patient information leaflet

Ketamine for nerve pain - patient information leaflet

Levomepromazine for nausea, vomiting, agitation, delirium - patient information leaflet

Lorazepam under the tongue - patient information leaflet

Morphine (Zomorph®) taken via enteral feeding tubes - patient information leaflet

Olanzapine to treat nausea and vomiting - patient information leaflet

Rectal diazepam for seizures - patient information leaflet

Risperidone orodispersible tablets to treat agitation and delirium - patient information leaflet

Syringe pump information - patient information leaflet

Glycopyrronium bromide for respiratory secretions

Opioids for breathlessness